Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial

por Veitonmäki, Thea, Murtola, Teemu J., Talala, Kirsi, Taari, Kimmo, Tammela, Teuvo, Auvinen, Anssi
Publicado 2016

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial

por Veitonmäki, T, Murtola, T J, Määttänen, L, Taari, K, Stenman, U-H, Tammela, T L J, Auvinen, A
Publicado 2014

Improved renal cancer prognosis among users of drugs targeting renin-angiotensin system

por Eskelinen, Tommi, Veitonmäki, Thea, Kotsar, Andres, Tammela, Teuvo L. J., Pöyhönen, Antti, Murtola, Teemu J.
Publicado 2021

Pre-clinical development of the human CD40 agonistic antibody ADC-1013

por Norlén, Per, Veitonmäki, Niina, Smith, Karin Enell, Tötterman, Thomas H, Mangsbo, Sara M, Furebring, Christina, Ellmark, Peter
Publicado 2015

ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer

por Mangsbo, Sara M, Broos, Sissela, Gustafsson, Erika, Furebring, Christina, Veitonmäki, Niina, Dahlen, Eva, Norlen, Per, Lindstedt, Malin, Tötterman, Thomas, Ellmark, Peter
Publicado 2013

The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice

por Mangsbo, Sara M, Veitonmäki, Niina, Gustfson, Erika, Smith, Karin Enell, Furebring, Christina, Norlén, Per, Lindstedt, Malin, Tötterman, Thomas H, Ellmark, Peter
Publicado 2014

The CTLA-4 x OX40 bispecific antibody ATOR-1015 induces anti-tumor effects through tumor-directed immune activation

por Kvarnhammar, Anne Månsson, Veitonmäki, Niina, Hägerbrand, Karin, Dahlman, Anna, Smith, Karin Enell, Fritzell, Sara, von Schantz, Laura, Thagesson, Mia, Werchau, Doreen, Smedenfors, Kristine, Johansson, Maria, Rosén, Anna, Åberg, Ida, Winnerstam, Magnus, Nyblom, Eva, Barchan, Karin, Furebring, Christina, Norlén, Per, Ellmark, Peter
Publicado 2019

The Bispecific Tumor Antigen-Conditional 4–1BB x 5T4 Agonist, ALG.APV-527, Mediates Strong T-Cell Activation and Potent Antitumor Activity in Preclinical Studies

por Nelson, Michelle H., Fritzell, Sara, Miller, Robert, Werchau, Doreen, Van Citters, Danielle, Nilsson, Anneli, Misher, Lynda, Ljung, Lill, Bader, Robert, Deronic, Adnan, Chunyk, Allison G., Schultz, Lena, Varas, Laura A., Rose, Nadia, Håkansson, Maria, Gross, Jane, Furebring, Christina, Pavlik, Peter, Sundstedt, Anette, Veitonmäki, Niina, Ramos, Hilario J., Säll, Anna, Dahlman, Anna, Bienvenue, David, von Schantz, Laura, McMahan, Catherine J., Askmyr, Maria, Hernandez-Hoyos, Gabriela, Ellmark, Peter
Publicado 2023